Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework

Area of Science:

• Cardiology
• Nephrology
• Molecular Biology
• Pathophysiology

Background:

• The heart and kidney are physiologically linked, with dysfunction in one organ impacting the other.
• Cardiorenal syndrome (CRS) is a complex condition involving acute or chronic dysfunction between the heart and kidneys.
• Classical risk factors like hypertension and dyslipidemia contribute, but molecular pathways are key.

Purpose of the Study:

• To elucidate the complex molecular mechanisms underlying cardiorenal syndrome.
• To explore the role of neurohumoral pathways and epigenetics in CRS pathogenesis.
• To identify potential targets for novel therapeutic strategies.

Main Methods:

• Review of existing literature on cardiorenal syndrome.
• Analysis of molecular pathways involved in heart-kidney crosstalk.
• Exploration of emerging epigenetic mechanisms in CRS.

Main Results:

• CRS involves intricate neurohumoral pathway activation, including the sympathetic nervous system, renin-angiotensin-aldosterone, endothelin, and arginine vasopressin systems.
• This activation leads to vascular inflammation, oxidative stress, atherosclerosis, cardiac hypertrophy, and fibrosis in both organs.
• Epigenetics represents a newly identified pathogenic route in CRS.

Conclusions:

• Cardiorenal syndrome is driven by complex molecular interactions, not just traditional risk factors.
• Understanding these pathways, including epigenetics, is crucial for developing effective treatments.
• Future research focusing on these molecular targets promises novel therapies for CRS.